2011Zhongguo yaofangRequires access

Pharmacokinetics and Bioequivalence of 3 Kinds of Sparfloxacin Preparations in Healthy Volunteers

Fan Li

Open publisher page 0 citations

Abstract

OBJECTIVE:To compare the pharmacokinetics of 3 kinds of sparfloxacin preparations in healthy volunteers,and to evaluate the bioequivalence of 3 kinds of preparations.METHODS:A total of 24 healthy volunteers received a single dose of Sparfloxacin capsules 400 mg (test preparation 1),Sparfloxacin tablets 400 mg (test preparation 2) or Sparfloxacin capsules 400 mg (reference preparation) respectively.The plasma concentrations of sparfloxacin were determined by HPLC.The pharmacokinetic parameters and bioequivalence of sparfloxacin were calculated using DAS2.1.1 software.RESULTS:The main pharmacokinetic parameters of test preparation 1,test preparation 2 and reference preparation were as follows:cmax(1.614±0.572)μg·mL-1,(1.760±0.498) μg·mL-1,(1.609±0.419)μg·mL-1;tmax(4.563±2.188) h,(4.708±2.116) h,(4.542±2.226) h;t1/2(21.890±5.150)h,(21.954±6.808)h,(23.336±5.762)h;AUC0~72h(42.809±12.684)μg·h·mL-1,(44.559±10.787)μg·h·mL-1,(43.193±8.757)μg·h·mL-1;AUC0~∞(48.149±14.678)μg·h·mL-1,(50.697±14.812)μg·h·mL-1,(49.588±11.484)μg·h·mL-1.F0~72h of test preparation 1 and test preparation 2 were(104.2±25.9)% and (96.9±20.7)%.There was no significant difference in cmax,tmax,AUC0~72h and AUC0~∞ among 3 kinds of preparations.CONCLUSION:Sparfloxacin capsules,Sparfloxacin tablets and reference preparation are bioequivalent.

About this research paper

What this paper is about

OBJECTIVE:To compare the pharmacokinetics of 3 kinds of sparfloxacin preparations in healthy volunteers,and to evaluate the bioequivalence of 3 kinds of preparations.METHODS:A total of 24 healthy volunteers received a single dose of Sparfloxacin capsules 400 mg (test preparation 1),Sparfloxacin tablets 400 mg (test preparation 2) or Sparfloxacin capsules 400 mg (reference preparation) respectively.The plasma concentrations of sparfloxacin were determined by HPLC.The pharmacokinetic parameters and bioequivalence of sparfloxacin were calculated using DAS2.1.1 software.RESULTS:The main pharmacokinetic parameters of test preparation 1,test preparation 2 and reference preparation were as follows:cmax(1.614±0.572)μg·mL-1,(1.760±0.498) μg·mL-1,(1.609±0.419)μg·mL-1;tmax(4.563±2.188) h,(4.708±2.116) h,(4.542±2.226) h;t1/2(21.890±5.150)h,(21.954±6.808)h,(23.336±5.762)h;AUC0~72h(42.809±12.684)μg·h·mL-1,(44.559±10.787)μg·h·mL-1,(43.193±8.757)μg·h·mL-1;AUC0~∞(48.149±14.678)μg·h·mL-1,(50.697±14.812)μg·h·mL-1,(49.588±11.484)μg·h·mL-1.F0~72h of test preparation 1 and test preparation 2 were(104.2±25.9)% and (96.9±20.7)%.There was no significant difference in cmax,tmax,AUC0~72h and AUC0~∞ among 3 kinds of preparations.CONCLUSION:Sparfloxacin capsules,Sparfloxacin tablets and reference preparation are bioequivalent.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

OBJECTIVE:To compare the pharmacokinetics of 3 kinds of sparfloxacin preparations in healthy volunteers,and to evaluate the bioequivalence of 3 kinds of preparations.METHODS:A total of 24 healthy volunteers received a single dose of Sparfloxacin capsules 400 mg (test preparation 1),Sparfloxacin tablets 400 mg (test preparation 2) or Sparfloxacin capsules 400 mg (reference preparation) respectively.The plasma concentrations of sparfloxacin were determined by HPLC.The pharmacokinetic parameters and bioequivalence of sparfloxacin were calculated using DAS2.1.1 software.RESULTS:The main pharmacokinetic parameters of test preparation 1,test preparation 2 and reference preparation were as follows:cmax(1.614±0.572)μg·mL-1,(1.760±0.498) μg·mL-1,(1.609±0.419)μg·mL-1;tmax(4.563±2.188) h,(4.708±2.116) h,(4.542±2.226) h;t1/2(21.890±5.150)h,(21.954±6.808)h,(23.336±5.762)h;AUC0~72h(42.809±12.684)μg·h·mL-1,(44.559±10.787)μg·h·mL-1,(43.193±8.757)μg·h·mL-1;AUC0~∞(48.149±14.678)μg·h·mL-1,(50.697±14.812)μg·h·mL-1,(49.588±11.484)μg·h·mL-1.F0~72h of test preparation 1 and test preparation 2 were(104.2±25.9)% and (96.9±20.7)%.There was no significant difference in cmax,tmax,AUC0~72h and AUC0~∞ among 3 kinds of preparations.CONCLUSION:Sparfloxacin capsules,Sparfloxacin tablets and reference preparation are bioequivalent.

Key concepts: Sparfloxacin, Bioequivalence, Cmax, Pharmacokinetics, Pharmacology, Chromatography, Medicine, High-performance liquid chromatography

Related papers

Back to paper searchBrowse research topicsOriginal source
Pharmacokinetics and Bioequivalence of 3 Kinds of Sparfloxacin Preparations in Healthy Volunteers — Research Paper | ScholarLens